Skip to main content
. Author manuscript; available in PMC: 2021 Aug 12.
Published in final edited form as: J Heart Lung Transplant. 2019 Jun 20;38(9):972–981. doi: 10.1016/j.healun.2019.06.006

Figure 1.

Figure 1.

Probability of freedom from any type of rejection (A) recurrent rejection (2 or more episodes) (B), acute cellular rejection (C), antibody mediated rejection (D) and rejection with hemodynamic compromise (E) in the first year post-transplant with corresponding 95% confidence interval. The number of participants at risk is presented at select time points along the x-axis. Censored data is shown as circles.